Dexcom (DXCM) Total Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Total Non-Current Liabilities data on file, last reported at $3.5 billion in Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 18.46% year-over-year to $3.5 billion in Q1 2026; TTM through Mar 2026 was $3.5 billion, a 18.46% decrease from a year earlier, with the FY2025 full-year figure at $3.5 billion, down 18.36% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $3.5 billion, up from $3.5 billion in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for DXCM reached as high as $4.6 billion in Q3 2025 and fell as low as $2.8 billion in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $3.8 billion across 5 years, with a median of $4.1 billion in 2024.
• Across the five-year window, Total Non-Current Liabilities soared 60.28% in 2023 and dropped 18.46% in 2026, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $3.1 billion in 2022, then climbed by 29.98% to $4.1 billion in 2023, then climbed by 4.02% to $4.2 billion in 2024, then retreated by 18.36% to $3.5 billion in 2025, then rose by 2.25% to $3.5 billion in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $3.5 billion in Q1 2026, $3.5 billion in Q4 2025, and $4.6 billion in Q3 2025.